Výsledky vyhledávání - "Nascimben, O."

The tumour associated antigen CA15.3 in primary breast cancer. Evaluation of 667 cases

Autor: Massimo Gion, Nascimben O, G Bruscagnin, C. Gatti, R Mione, Antonette E. Leon, M Valsecchi

Publikováno v: British Journal of Cancer

CA15.3 preoperatory serum levels have been determined in 667 patients with primary untreated breast cancer and in 193 controls. The relationships between CA15.3 and several clinical and pathological parameters were evaluated. CA15.3 levels showed a h

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9f87da29f4d38aad6aff55fbf0fe578
http://europepmc.org/articles/PMC1972400

Zobrazit plný text záznamu

Adjuvant chemotherapy with high dose epirubicin and cyclophosphamide (EC) vs cyclophosphamide, methotrexate, fluorouracil (CMF) in high risk premenopausal breast cancer patients. 97

Autor: Cetto, Gianluigi, Galligioni, E., Nascimben, O., Buonadonna, A., Crivellari, D., Molino, Annamaria, Veronesi, A., Graiff, C., Barni, S., Puccetti, C., Ferrazzi, E., Recaldin, E., Sacco, C., G. O. C. C. N. E.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1943::3dcf2e19e6738580caeff03cd52002ad
http://hdl.handle.net/11562/310095

Zobrazit plný text záznamu

Adjuvant chemotherapy with high dose epirubicin and cyclophosphamide (ec) vs cyclophosphamide, methotrexate, fluorouracil (CMF) in high risk premenopausal breast cancer patients (PTS). A prospective randomized trial. E

Autor: Galligioni, E., Cetto, Gianluigi, Nascimben, O., Buonadonna, A., Crivellari, D., Molino, Annamaria, Veronesi, A., Graiff, C., Barni, S., Puccetti, C., Ferrazzi, E., Recaldin, E., Sava, C., Saracchini, S., Sacco, C.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1943::89ebdc26f29592fbf2ca211c4e5789bf
http://hdl.handle.net/11562/310051

Zobrazit plný text záznamu

High dose Epirubicine and Cyclophosphamide (EC) vs Cyclophosphamide, Methotrexate, Fluorouracil (CMF) as adjuvant chemotherapy in high risk premenopausal breast cancer patients (PTS). A prospective randomized trial

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1943::a75d6a24ed684e19989ac5eba76c05e6
http://hdl.handle.net/11562/310055

Zobrazit plný text záznamu

PS2 in breast cancer--alternative or complementary tool to steroid receptor status? Evaluation of 446 cases

Autor: R Mione, M. Bari, Pappagallo Gl, G Bruscagnin, Massimo Gion, C. Gatti, Antonette E. Leon, Orazio Vinante, Nascimben O

Publikováno v: British Journal of Cancer

The oestrogen induced pS2 protein was measured in the cytosol of 446 breast cancer samples by an immunoradiometric assay. The relationships between pS2 and several clinical and biological parameters were evaluated. pS2 was not correlated to age, pT a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2eddc5262869c3aed944c272a09ed4bd
https://pubmed.ncbi.nlm.nih.gov/8347494

Zobrazit plný text záznamu

Phase I-II intraperitoneal mitoxantrone in advanced pretreated ovarian cancer

Autor: Nicoletto, M. O., Padrini, Roberto, Ferrazzi, E., Nascimben, O., Visona, E., Tumolo, S., Palumbo, Manlio, Costa, L., Vinante, O., Monfardini, S.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3657::d3e51b1f29756acbc3328a5740b17725
http://hdl.handle.net/11577/2500842

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání